Aptachem Consulting
Consulting firm providing chemistry and discovery support to small companies, academic groups, biotech and investors. Services focus on medicinal chemistry and drug design, program assessment and due diligence, CRO collaboration and management, patent strategy, project management, and lab start-up and operations. Founder-led practice with multi-decade experience in pharmaceutical research, CRO oversight, and intellectual property assessment.
Industries
Nr. of Employees
small (1-50)
Aptachem Consulting
Apex, North Carolina, United States, North America
Services
Consulting support for design of therapeutic small molecules, early discovery triage, hit identification and lead optimization.
Selection, engagement and management of CROs for chemistry, biology, ADMET/DMPK, toxicology and in vivo studies.
Technical due diligence, data package analysis, tech transfer support and investor-focused assessments.
Patentability searches, landscape analyses, application assembly and coordination with patent counsel focused on composition-of-matter issues.
Program-level coordination including scope, schedule, resource management and data capture to maintain project momentum.
Early-stage lab planning including facilities and equipment procurement, staffing and operational workflows.
Consulting support for design of therapeutic small molecules, early discovery triage, hit identification and lead optimization.
Selection, engagement and management of CROs for chemistry, biology, ADMET/DMPK, toxicology and in vivo studies.
Technical due diligence, data package analysis, tech transfer support and investor-focused assessments.
Patentability searches, landscape analyses, application assembly and coordination with patent counsel focused on composition-of-matter issues.
Program-level coordination including scope, schedule, resource management and data capture to maintain project momentum.
Early-stage lab planning including facilities and equipment procurement, staffing and operational workflows.
Expertise Areas
- Medicinal chemistry
- Small-molecule drug discovery
- Structure- and fragment-based design
- Cheminformatics and computational chemistry
Key Technologies
- Structure-based drug design
- Fragment-based design
- Parallel synthesis
- Cheminformatics